In 2024, the FDA approved resmetirom (Rezdiffra) for adults with noncirrhotic NASH with F2F3 fibrosis, marking the first approved pharmacotherapy specifically for this condition
Folliculotropic metastasis of cutaneous melanoma is rare, with only five published case reports [42], but a history of previous melanoma and the presence of multiple lesions favor its diagnosis [43, 44]
The association was strongest at weight-loss dosages and with longer treatment duration
It is available in three different forms like injectables, oral form and topical form
It has been demonstrated that Zn(II) ions inhibit the activation of the NF-B factor, which is responsible for the expression of pro-inflammatory molecules such as IL-1, IL-6, IL-8, and TNF-, as well as pro-inflammatory enzymes like cyclooxygenases and nitric oxide synthase (Prasad 2014)